Insulin Glargine is a long-acting type of insulin used to treat types 1 and 2 diabetes mellitus in both adults and children. It provides a steady level of insulin in the body for an entire day and ...

Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Amylin is a hormone co-secreted with insulin in the pancreas that has anorexigenic effects, since it promotes satiety and reduces food intake. Amylin analogs and dual agonists of the amylin and ...

Departments of Pharmacology, UT Southwestern Medical Center, Dallas, USA Departments of Peter O’Donnell Jr. Brain Institute and Psychiatry, UT Southwestern Medical Center, Dallas, USA Department of ...

Eli Lilly's efsitora alfa was noninferior to once-daily insulin in type 2 diabetes, but an increased hypoglycemia risk was seen in type 1 diabetes.

If you've recently received a diagnosis of type 2 diabetes, understanding your treatment options is an important first step.

Key drivers include technological advancements and evolving healthcare policies. The global market for short-acting insulin ...

The authors convincingly demonstrate, using a battery of experimental techniques and relying on the mapped whole brain connectome, how the heterogeneity in the responses across individual IPCs occur ...

The PDUFA date refers to the deadline set by the US Food and Drug Administration for reviewing drug applications.

One of the biopharma industry’s marvels of the 2020s has been the enormous medical and financial success of the GLP-1 class ...

Semaglutide, a synthetic analog of glucagon-like peptide-1 (GLP-1), has garnered ... and adipose triglyceride lipase (ATGL), further supporting its role in fat regulation. Insulin sensitivity is ...